Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583070
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-24
Brief Title:
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
Sponsor:
Organization:
None